Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schiff Q2 results

This article was originally published in The Tan Sheet

Executive Summary

Sales for Schiff Nutrition decreased to $35.5 mil. for the second quarter of 2006 (ending Nov. 30, 2005) from $44.3 mil. for the prior-year period due to the "discontinuance of certain private label business," President and CEO Bruce Wood reports Jan. 12. "Our branded sales also declined slightly in the quarter, but they are up approximately 8% for the first six months," he states. Branded product sales are expected to increase in the third quarter with the launch of Move Free Advanced Formula joint product, according to the Salt Lake City, Utah-based firm. "We will be providing substantial marketing support for this proprietary new product beginning in our fiscal third quarter," Wood continued. The company's second quarter net income of $1.5 mil fell approximately $2 mil. from the year-ago period...
Advertisement

Related Content

Schiff earnings dip

Topics

Advertisement
UsernamePublicRestriction

Register

PS099013

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel